top of page

CRISPR-Based SARS-CoV-2 Saliva Test

Wainamics was chosen for this Innovative Genomics Institute project in Jennifer Doudna’s lab at UC Berkeley to provide expertise in microfluidic cartridge design and system architecture for a point-of-care saliva-based test combining isothermal amplification and a CAS-13 assay for high sensitivity, rapid testing for SARS-CoV-2.

Schematic of sample processing with CRISPR and LAMP

We optimized the cartridge design for multiplexing, enabling test results in less than 50 minutes, with 94% sensitivity and 100% specificity when validated against quantitative PCR.

Image of cartridge designs for CRISPR and LAMP assay

See the publication here.

Cover of Nature Biomedical Engineering
bottom of page